<DOC>
	<DOC>NCT00396513</DOC>
	<brief_summary>The purpose of this study is to compare effects of statins (simvastatin) and metformin on clinical (menstrual cycle, excessive hair, skin problems), endocrine (androgens), metabolic (lipids, markers of systemic inflammation), and endothelial function parameters in women with polycystic ovary syndrome (PCOS).</brief_summary>
	<brief_title>Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>PCO ESHRE/ASRM criteria:oligomenorrhea (&lt;8 spontaneus menses per year) and hyperandrogenism(hirsutism or acne) or hyperandrogenemia(testosterone &gt; 70 ng/ml) normal prolactin, TSH, 17OH progesterone no evidence of androgen producing malignancy, Cushing's syndrome or acromegaly age 1840 reliable use of birth control pill for at least 3 months and no plans of pregnancy elevated creatinine kinase above 2 times upper limit of normal or liver enzymes (transaminase) above 2 times of upper limit of normal use of any following medications: cyclosporine, fibrates niacin,antifungal agents, macrolide antibiotics use of oral contraceptives and other steroid hormones 3 months prior to the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>PCOS</keyword>
	<keyword>Statin</keyword>
	<keyword>Metformin</keyword>
	<keyword>Testosterone</keyword>
	<keyword>Menstrual cycle</keyword>
	<keyword>Lipids</keyword>
</DOC>